Intelligence Platform
Patents
Browse 677 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7378403
Akt inhibitors, pharmaceutical compositions, and uses thereof
granted patentUS 7378093
Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select
granted patentUS 7378276
Method of inducing memory B cell development and terminal differentiation
granted patentUS 7378277
Methods and compositions for transforming dendritic cells and activating T cells
granted patentUS 7374872
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
granted patentUS 7375185
Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
granted patentUS 7374756
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
granted patentUS 7371392
Cd40 ligand adjuvant for respiratory syncytial virus
granted patentUS 7371572
Mouse titers after two immunizations with VLPs alone
granted patentUS 7368116
Method of enhancing a targeted immune response against tumors
granted patentUS 7368106
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment
granted patentUS 7368110
Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for
granted patentUS 7368114
Fusion protein including of CD4
granted patentUS 7364719
Vasoregulating compounds and methods of their use
granted patentUS 7361664
Vitamin D receptor antagonists and related compositions and methods of use
granted patentUS 7361356
Self-assembling recombinant papillomavirus capsid proteins
granted patentUS 7338807
Screening assays for compounds that cause apoptosis
granted patentUS 7339037
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v
granted patentUS 7335749
Tumor suppressor gene, p47Ing3
granted patentUS 7332590
Molecular characteristics of non-small cell lung cancer
granted patentUS 7332645
IL-21 as a regulator of immunoglobin production
granted patentUS 7330748
Method for determining in vivo concentration of a metabolite
granted patentUS 7329502
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma
granted patentUS 7314631
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains
granted